Engineering CAR-Vδ2 T cells to boost persistence and anti-tumor function
Preprint
Abstract
Chimeric antigen receptor (CAR)-modified Vδ2 T cells are an attractive therapeutic cell platform for cancer immunotherapy. However, their clinical efficacy is limited by short in vivo persistence due to insufficient cytokine support and high susceptibility to activation-induced cell death (AICD). Through comparison of membrane-bound (mb) cytokines, we identified mbIL-18 to support superior anti-tumor activity of CAR-Vδ2 T cells in vitro and in vivo . To reduce constitutive surface exposure of IL-18 and enable antigen-driven signal 3, we fused MyD88 - the key IL-18R signaling mediator - to an extracellular domain of Fas (Fas88). Antigen stimulation-induced FasL engagement of Fas88 triggered IL-18 signaling while simultaneously protecting Vδ2 T cells from AICD. Fas88-armed human CAR-Vδ2 T cells produced superior yet stimulation-dependent in vivo expansion and functional persistence in xenograft models of hematologic and solid malignancies. Together, these findings highlight the importance of IL-18 signaling and AICD resistance for CAR-Vδ2 T cell activity, enabling a single-transgene modification to limit inflammatory risk and facilitate clinical translation.Keywords
This publication has 68 references indexed in Scilit:
- γδ T cells for cancer immunotherapy: A 2024 comprehensive systematic review of clinical trials2024
- Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosisCytotherapy, 2024
- Effective γδ T‐cell clinical therapies: current limitations and future perspectives for cancer immunotherapyClinical & Translational Immunology, 2024
- Safety switches for adoptive cell therapyCurrent Opinion in Immunology, 2022
- Generation of CAR T-cells using γ-retroviral vector2021
- Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune SystemCell Reports, 2018
- Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-DependentCell Reports, 2017
- Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18Cell Reports, 2017
- Differentiation of Resting Human Peripheral Blood γδ T Cells toward Th1- or Th2-PhenotypeCellular Immunology, 2001
- Differential Susceptibility of Naïve and Activated Human γδ T Cells to Activation-Induced Cell Death by T-Cell Receptor Cross-LinkingMolecular Medicine, 2001